Biodegradable stents for coronary artery disease treatment: Recent advances and future perspectives

Tingzhang Hu1, Chun Yang1, Song Lin1

  • 1Key Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing 400030, China.

Insights

Biodegradable stents (BDSs) offer a promising alternative to metallic stents for treating cardiovascular diseases by reducing long-term side effects. Future research focuses on optimizing BDS structure, materials, and drug delivery for improved performance and patient outcomes.

Area of Science:

  • Biomaterials Science
  • Cardiovascular Engineering
  • Medical Device Development

Background:

  • Cardiovascular diseases remain a leading global cause of mortality.
  • Metallic endovascular stents, crucial for cardiovascular interventions, face challenges like thrombosis and restenosis.
  • Biodegradable stents (BDSs) are emerging as a next-generation solution to mitigate these long-term complications.

Purpose of the Study:

  • To review the properties and working principles of various biodegradable stent materials.
  • To discuss desirable features and necessary compromises in BDS design, balancing radial support and degradation.
  • To outline future research strategies for successful BDS development and application.

Main Methods:

  • Literature review summarizing properties of polymeric, iron-, magnesium-, and zinc-based BDSs.
  • Analysis of BDS working principles and design considerations.
  • Discussion of future research directions including structural optimization, material enhancement, and drug loading.

Main Results:

  • Various BDS materials exhibit distinct mechanical properties, degradation rates, and biocompatibility profiles.
  • Achieving an optimal balance between radial support and degradation is a key challenge in BDS design.
  • Finite element analysis, material improvements, and drug-eluting capabilities are identified as crucial for future BDS development.

Conclusions:

  • Biodegradable stents hold significant promise for improving cardiovascular disease treatment by overcoming limitations of metallic stents.
  • Further research is essential to optimize BDS structure, mechanical performance, degradation kinetics, and biocompatibility.
  • Addressing current limitations will pave the way for successful clinical translation and widespread application of BDSs.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
500
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
289
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
399
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K